Ignite Creation Date:
2024-05-05 @ 5:12 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00406497
Status:
COMPLETED
Last Update Posted:
2006-12-04
First Post:
2006-11-29
Brief Title:
Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Sponsor:
Sirion Therapeutics Inc
Organization:
Sirion Therapeutics Inc
Study Overview
Official Title:
Phase 2a Study of 005 Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation
Status:
COMPLETED
Status Verified Date:
2006-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this phase 2 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation
Detailed Description:
The objective is to assess efficacy endpoints in comparison with 01 BM ophthalmic solution prior to investigation of the efficacy and safety of 005 DFBA ophthalmic emulsion in the treatment of postoperative intraocular inflammation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None